The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durvalumab consolidation therapy following chemoradiotherapy among patients with unresectable stage III non-small cell lung cancer (NSCLC) treated in a U.S. community oncology network.
 
David Michael Waterhouse
Consulting or Advisory Role - Abbvie; Amgen; AZTherapies; Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; Janssen Oncology; Jazz Pharmaceuticals; McGivney Global Advisors; Merck; Mirati Therapeutics; Pfizer; Sanofi/Regeneron; Seagen
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Janssen Oncology; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Candice Yong
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Nicholas J. Robert
Employment - McKesson
Leadership - McKesson
Stock and Other Ownership Interests - Johnson & Johnson (I); McKesson; Oncolytics (I)
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Advi; Boehringer Ingelheim; Bristol-Myers Squibb; New Century Health
 
Kathleen M. Aguilar
Employment - IQvia (I); Ontada/McKesson
 
Juliet Ndukum
No Relationships to Disclose
 
Yiqiong Xie
Employment - Ontada/McKesson
 
Brian S. Seal
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Ion Cotarla
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Consulting or Advisory Role - Gerson Lehrman Group